| Primary |
| Asthma |
72.2% |
| Cough |
16.7% |
| Chronic Obstructive Pulmonary Disease |
5.6% |
| Drug Use For Unknown Indication |
2.8% |
| Hypersensitivity |
2.8% |
|
| Dyspnoea |
13.0% |
| Aggression |
8.7% |
| Anosmia |
4.3% |
| Anxiety |
4.3% |
| Arrhythmia |
4.3% |
| Asthma |
4.3% |
| Breath Odour |
4.3% |
| Cushing's Syndrome |
4.3% |
| Cushingoid |
4.3% |
| Dermatitis Allergic |
4.3% |
| Device Malfunction |
4.3% |
| Drug Ineffective |
4.3% |
| Hyperhidrosis |
4.3% |
| Loss Of Consciousness |
4.3% |
| Middle Insomnia |
4.3% |
| Nightmare |
4.3% |
| Pharmaceutical Product Complaint |
4.3% |
| Product Substitution Issue |
4.3% |
| Psychosomatic Disease |
4.3% |
| Psychotic Disorder |
4.3% |
|
| Secondary |
| Asthma |
32.1% |
| Product Used For Unknown Indication |
21.4% |
| Dyspnoea |
10.7% |
| Drug Use For Unknown Indication |
6.2% |
| Chronic Obstructive Pulmonary Disease |
4.9% |
| Cough |
4.1% |
| Bronchiectasis |
2.9% |
| Leukaemia |
2.5% |
| Migraine |
2.1% |
| Cancer Pain |
1.6% |
| Gastritis Prophylaxis |
1.6% |
| Hypertension |
1.6% |
| Asthma Exercise Induced |
1.2% |
| Bronchitis |
1.2% |
| Hypothyroidism |
1.2% |
| Rheumatoid Arthritis |
1.2% |
| Antiretroviral Therapy |
0.8% |
| Blood Testosterone Decreased |
0.8% |
| Constipation |
0.8% |
| Haemoglobin Decreased |
0.8% |
|
| Drug Ineffective |
12.8% |
| Asthma |
8.5% |
| Therapeutic Response Decreased |
8.5% |
| Ventricular Fibrillation |
8.5% |
| Congenital Hydrocephalus |
6.4% |
| Dyspnoea |
6.4% |
| Oral Discomfort |
6.4% |
| Speech Disorder |
6.4% |
| Arthritis |
4.3% |
| Dental Caries |
4.3% |
| Hyponatraemia |
4.3% |
| Oropharyngeal Discomfort |
4.3% |
| Swelling Face |
4.3% |
| Abdominal Discomfort |
2.1% |
| Abdominal Pain Upper |
2.1% |
| Aggression |
2.1% |
| Aphasia |
2.1% |
| Benign Prostatic Hyperplasia |
2.1% |
| Blood Pressure Increased |
2.1% |
| Cerebrovascular Accident |
2.1% |
|
| Concomitant |
| Product Used For Unknown Indication |
28.3% |
| Drug Use For Unknown Indication |
23.5% |
| Asthma |
20.7% |
| Chronic Obstructive Pulmonary Disease |
5.2% |
| Hypertension |
3.7% |
| Hypersensitivity |
2.1% |
| Depression |
2.0% |
| Gastrooesophageal Reflux Disease |
1.9% |
| Pain |
1.8% |
| Atrial Fibrillation |
1.2% |
| Emphysema |
1.2% |
| Rheumatoid Arthritis |
1.1% |
| Rhinitis Allergic |
1.1% |
| Osteoporosis |
1.1% |
| Multiple Myeloma |
1.0% |
| Arthritis |
0.9% |
| Hypothyroidism |
0.9% |
| Prophylaxis |
0.9% |
| Blood Cholesterol Increased |
0.8% |
| Anxiety |
0.8% |
|
| Vomiting |
10.8% |
| Asthma |
8.2% |
| Wheezing |
7.8% |
| Dyspnoea |
5.9% |
| Urticaria |
5.7% |
| Drug Ineffective |
5.5% |
| Weight Increased |
5.3% |
| Weight Decreased |
5.1% |
| Nausea |
4.6% |
| Visual Impairment |
4.6% |
| Pneumonia |
4.0% |
| Tremor |
4.0% |
| Pruritus |
3.8% |
| Pyrexia |
3.8% |
| Hypotension |
3.6% |
| Malaise |
3.6% |
| Oedema Peripheral |
3.6% |
| Anaphylactic Reaction |
3.4% |
| Atrial Fibrillation |
3.4% |
| Hypersensitivity |
3.4% |
|
